.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
UBS
Argus Health
Cantor Fitzgerald
AstraZeneca
Chinese Patent Office
QuintilesIMS
Fuji
US Department of Justice
Novartis

Generated: December 14, 2017

DrugPatentWatch Database Preview

Patents Expiring in October 2023

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Purdue PharmaRYZOLTtramadol hydrochlorideTABLET, EXTENDED RELEASE;ORAL021745-001Dec 30, 2008DISCNYesNo► Subscribe► Subscribe► SubscribeY
Purdue PharmaRYZOLTtramadol hydrochlorideTABLET, EXTENDED RELEASE;ORAL021745-002Dec 30, 2008DISCNYesNo► Subscribe► Subscribe► SubscribeY
NovartisRECLASTzoledronic acidINJECTABLE;IV (INFUSION)021817-001Apr 16, 2007APRXYesYes► Subscribe► Subscribe► SubscribeTREATMENT AND PREVENTION OF POSTMENOPAUSAL OR GLUCOCORTICOID-INDUCED OSTEOPOROSIS AND TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS
Purdue PharmaRYZOLTtramadol hydrochlorideTABLET, EXTENDED RELEASE;ORAL021745-003Dec 30, 2008DISCNYesNo► Subscribe► Subscribe► SubscribeY
Bayer HlthcareFINACEA azelaic acidAEROSOL, FOAM;TOPICAL207071-001Jul 29, 2015RXYesYes► Subscribe► Subscribe► SubscribeY
Bayer HlthcareFINACEA azelaic acidAEROSOL, FOAM;TOPICAL207071-001Jul 29, 2015RXYesYes► Subscribe► Subscribe► SubscribeY
Luitpold Pharms IncINJECTAFERferric carboxymaltoseINJECTABLE;INTRAVENOUS203565-001Jul 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeYY
Novartis Pharms CorpVOTRIENTpazopanib hydrochlorideTABLET;ORAL022465-001Oct 19, 2009RXYesYes► Subscribe► Subscribe► SubscribeYY
Novartis Pharms CorpVOTRIENTpazopanib hydrochlorideTABLET;ORAL022465-002Oct 19, 2009DISCNNoNo► Subscribe► Subscribe► SubscribeYY
Septodont HoldingORAVERSEphentolamine mesylateINJECTABLE;INJECTION022159-001May 9, 2008RXYesYes► Subscribe► Subscribe► SubscribeA METHOD OF REVERSING SOFT-TISSUE ANESTHESIA I.E. ANESTHESIA OF THE LIP AND TONGUE, AND THE ASSOCIATED FUNCTIONAL DEFICITS RESULTING FROM AN INTRAORAL SUBMUCOSAL INJECTION OF A LOCAL ANESTHETIC
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Covington
Merck
Fish and Richardson
Mallinckrodt
Chinese Patent Office
Healthtrust
Cipla
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot